The pharmaceutical company at the center of the EpiPen price-gouging controversy has decided to lower the cost of its medication for some patients.

Mylan, which had hiked the price of the medication by more than 400 percent, announced plans to cover up to $300 — or roughly 50 percent — of the cost of a pack of two EpiPens for patients who were paying the full amount.